United Bancshares Inc Revenue Growth Rates (UPOH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
United Bancshares Inc  (UPOH)
 

UPOH's Revenue Growth by Quarter and Year

United Bancshares Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UPOH Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
4th Quarter December -
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.87
FY 0.87





UPOH Revenue third quarter 2015 Y/Y Growth Comment
United Bancshares Inc in the third quarter 2015 recorded of $ 0.00 millions.

According to the results reported in the third quarter 2015, United Bancshares Inc achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While United Bancshares Inc' s Revenue meltdown of -100% ranks overall at the positon no. in the third quarter 2015.


UPOH Revenue ( Y/Y Growth %) 2015
 2014 2013 2012
4th Quarter December - - - -
3rd Quarter September - 31.33 % - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - 21.3 % - -

Financial Statements
United Bancshares Inc's third quarter 2015 Revenue $ 0.00 millions UPOH's Income Statement
United Bancshares Inc's third quarter 2014 Revenue $ 1.09 millions Quarterly UPOH's Income Statement


UPOH Revenue (Quarter on Quarter Growth %)

 2015
 2014 2013 2012
4th Quarter December - -11.93 % - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March -9.37 % - - -
FY (Year on Year)   - 21.3 % - -


Back to UPOH Growth rate Comparisons >> Back to UPOH Growth rate Comparisons >>


Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

United Bancshares Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


UPOH's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


UPOH's III. Quarter Q/Q Revenue Comment


United Bancshares Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2015)		 12 Months Ending
(Jun 30 2015)		 12 Months Ending
(Mar 31 2015)		 12 Months Ending
(Dec 31 2014)		 12 Months Ending
(Sep 30 2014)
Cumulative Revenue 12 Months Ending $ 3.75 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment


United Bancshares Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment


United Bancshares Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
UPOH's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2019
Waters Corporation-0.13%$ -0.129 millions
Vaso Corporation-0.32%$ -0.325 millions
Nature s Sunshine Products inc -0.34%$ -0.342 millions
Myomo Inc -0.39%$ -0.388 millions
Integer Holdings Corporation-0.49%$ -0.492 millions
Prestige Consumer Healthcare Inc -0.54%$ -0.538 millions
Dariohealth Corp -0.59%$ -0.585 millions
Alpha Pro Tech Ltd -0.64%$ -0.636 millions
Vivus Inc-0.65%$ -0.652 millions
Aptinyx Inc -0.74%$ -0.742 millions
Supernus Pharmaceuticals inc -0.83%$ -0.831 millions
Pediatrix Medical Group Inc -0.89%$ -0.890 millions
Atrion Corporation-1.00%$ -0.996 millions
Livanova Plc-1.28%$ -1.276 millions
Assembly Biosciences Inc -1.28%$ -1.280 millions
Magellan Health inc -1.33%$ -1.325 millions
Rvl Pharmaceuticals Plc-1.33%$ -1.332 millions
Scientific Industries Inc -1.69%$ -1.687 millions
3m Company-1.97%$ -1.975 millions
Endo International Plc-2.15%$ -2.152 millions
Intersect Ent Inc -2.47%$ -2.473 millions
Nymox Pharmaceutical Corporation-2.50%$ -2.500 millions
United Therapeutics Corporation-2.71%$ -2.714 millions
Amgen Inc -2.83%$ -2.829 millions
Envista Holdings Corporation-2.97%$ -2.973 millions
Arcturus Therapeutics Holdings Inc -3.07%$ -3.067 millions
Theravance Biopharma inc -3.20%$ -3.201 millions
Autolus Therapeutics Plc-3.26%$ -3.257 millions
Enovis Corp-3.30%$ -3.296 millions
Musclepharm Corporation-3.46%$ -3.465 millions


About United Bancshares Inc Revenue Growth Rates (UPOH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.